BillionToOne, Inc. (BLLN)
Thursday, November 5, 2026
Key stats
Chart
Price, buy and sell signals and key levels on one chart.
Past 1Y
MA21MA180
SignalsBuyEarly buySellEarly sellTurning pointsSwing highSwing low
Up dayDown day
Thursday, November 5, 2026
Price, buy and sell signals and key levels on one chart.
BillionToOne (BLLN) closed at $113.89 on Nov 4, 2026, up 3.1% on the day. The stock is up 14.0% over the past month, up 24.3% over three months and up 39.2% year to date. It trades 24.3% below its 52-week high of $150.44 and 83.8% above its 52-week low of $61.96. The close sits above its 50-day moving average ($104.67) and above its 200-day moving average ($96.76).
Yes — the Nov 4, 2026 close of $113.89 is 17.7% above the 200-day average of $96.76.
BLLN closed 24.3% below its 52-week high of $150.44.
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a methylation-based assay that quantifies the amount of cancer at the single molecule level without requiring a tissue biopsy, enabling real-time monitoring of patient response to therapy with unprecedented precision. BillionToOne, Inc. was incorporated in 2016 and is headquartered in Menlo Park, California.